About Jay Lichter, Ph.D.
Jay Lichter, Ph.D. is a director at Arialys Therapeutics.
Jay Lichter, Ph.D. first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jay Lichter, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jay Lichter, Ph.D. works with at each company, as listed on that company's latest Form D.
Arialys Therapeutics, Inc. · Form D, Jul 1, 2025
PD
Peter Flynn, Ph.D.
Chief Executive Officer and director
BH
EH
Ed Hurwitz
Director
AD
Ashish Xavier, Ph.D.
Director